Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical Study
NCT ID: NCT02142946
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2018-04-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis
NCT02759211
Balance Measures During Stance and Gait: Comparison of Gyroscopic Measurements of Trunk Sway
NCT02509455
Sensori-motor Integration Training in Multiple Sclerosis
NCT01040117
Stabilometric Assessment of Balance Recovery in Persons With Multiple Sclerosis
NCT02131285
Motor-cognitive Performance in People With Multiple Sclerosis
NCT06312046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RIS MS patients
Radiologically Isolated Syndrome (RIS) MS patients
No interventions assigned to this group
CIS MS patients
Clinically Isolated Syndrome (CIS) patients during a stable phase
No interventions assigned to this group
RRMS patients
Relapsing-remitting (RR) MS patients during a stable phase
No interventions assigned to this group
SPMS Patients
Secondary progressive MS patients (SPMS)
No interventions assigned to this group
PPMS Patients
Primary progressive MS patients (PPMS)
No interventions assigned to this group
Controls
Age and gender matched controls
No interventions assigned to this group
CI Patients
Cochlear Implant patients pre- and post-operatively
No interventions assigned to this group
UVL Patients
Unilateral vestibular loss patients in acute and compensated state
No interventions assigned to this group
Chronic UVL
Chronic unilateral vestibular loss patients
No interventions assigned to this group
Phobic
Phobic vertigo patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John HJ Allum, DSc
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lab for Exp Otoneurology, University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.